We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Voice outcomes after concurrent chemoradiotherapy for advanced nonlaryngeal head and neck cancer: A prospective study.
- Authors
Paleri, Vinidh; Carding, Paul; Chatterjee, Sanjoy; Kelly, Charles; Wilson, Janet Ann; Welch, Andrew; Drinnan, Michael
- Abstract
Background The voice impact of treatment for nonlaryngeal head and neck primary sites remains unknown. Methods We conducted a prospective study of a consecutive sample of patients undergoing chemoradiation for nonlaryngeal head and neck cancer. The Voice Symptom Scale (VoiSS) was completed, and voice recordings were made at 3 time-points. Results Of 42 recruited patients, 34 completed the measures before and in the early posttreatment phase (mean 16.5 weeks), while 21 patients were assessed at the final time-point (mean, 20.4 months). VoiSS scores showed statistically significant progressive deterioration in the total score ( p = .02) and impairment subscale ( p < .0001) through to the final assessment. Acoustic measures and perceptual ratings deteriorated significantly ( p < .001) in the early posttreatment weeks and improved at the final assessment, but not to the baseline. Interrater agreement was excellent for expert measures. Conclusion To the best of our knowledge, this is the first prospective study to show that chemoradiation therapy for nonlaryngeal head and neck cancer has a significant effect on the patients' self-reported voice quality, even in the long term. © 2012 Wiley Periodicals, Inc. Head Neck, 2012
- Subjects
LONGITUDINAL method; RADIOTHERAPY; HEAD &; neck cancer treatment; CANCER chemotherapy; STATISTICAL significance; VOICE analysis
- Publication
Head & Neck, 2012, Vol 34, Issue 12, p1747
- ISSN
1043-3074
- Publication type
Article
- DOI
10.1002/hed.22003